Role of Antigen-Specific T Cell Responses in the Control of TB |
Joel D. Ernst, MD |
Tuberculosis, Immunology |
|
|
Antigen export in M. tuberculosis evasion of CD4 T cells |
Joel D. Ernst, MD |
Tuberculosis, Immunology |
|
|
Cellular and Bacterial Dynamics in Tuberculosis |
Joel D. Ernst, MD |
Tuberculosis, Immunology |
|
|
Clinical trials to improve the treatment of drug-sensitive and MDR-TB |
Patrick Phillips, PhD, MS, MA |
Tuberculosis, Immunology, Pharmacology and Drug Treatment |
|
|
Dissecting the effect of paracrine responses to Zika virus on neurodevelopment in the human brain |
Hanna Retallack, AB |
Zoonosis, Emerging Disease, and Drug Resistance, Immunology |
|
|
IgA regulation of mucosal biome |
Keith Mostov, MD, PhD |
Immunology |
|
|
Role of Ceramide in Hepatic Stellate Cell Activation and Liver Fibrosis |
Jennifer Chen, MD |
Immunology |
|
|
Quantitative mapping of interactions between dengue virus and its hosts |
|
Zoonosis, Emerging Disease, and Drug Resistance, Immunology |
|
|
Vertical Transmission of Zika Virus: Histopathological Investigations at the Maternal- Fetal Interface |
Stephanie Valderramos, MD, PhD |
Infectious Disease, Drug and Diagnostics Development, Immunology |
|
|
Placental Malaria: The Role of Macrophages in Placental Inflammation - RSDP Valderramos |
Stephanie Valderramos, MD, PhD |
Malaria, Immunology |
|
|
Placental malaria: The role of inflammation at the maternal-fetal interface |
Stephanie Valderramos, MD, PhD |
Malaria, Immunology, Labor and Delivery, Newborn and Infant Health |
|
|
Placental Malaria: The Role of Macrophages in Placental Inflammation - RSDP Valderramos Burroughs Wellcome Fund |
Stephanie Valderramos, MD, PhD |
Malaria, Immunology |
|
|
Immunology & epidemiology of intestinal infectious diseases |
Robert Owen, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Immunology, Epidemiology and Surveillance |
|
|
Transfusion science and HIV, HTLV, and dengue research in Brazil |
Philip Norris, MD |
Infectious Disease, HIV/AIDS, Immunology, Health Systems Strengthening, Risk Reduction and Prevention, Training and Capacity Building |
|
|
Developing new vaccines for Global Health applications |
|
Drug and Diagnostics Development, Immunology |
|
|
Effects of Viral Escape on Memory T-Cell Muturation |
Eric Delwart, PhD |
Immunology |
|
|
Biomedical simulation models describing how molecular level events effect changes in phenotype |
C. Anthony Hunt, PhD |
Immunology, Genetics |
|
|
HARC Center: HIV Accessory and Regulatory Complexes |
Alan Frankel, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Immunology |
|
|
Optogenetic dissection of the growth and activation network in T cells |
|
Immunology |
|
|
HIV Cures - Paving the way towards elimination of HIV persistent CD4 T cell in vivo |
|
HIV/AIDS, Immunology |
|
|
Single Cell Characterization of Latent HIV-1 Reservoirs |
|
HIV/AIDS, Immunology |
|
|
Targeting latent HIV-1 Reservoirs with the Antibody-Drug Conjugate, Brentuximab Vedotin |
|
HIV/AIDS, Immunology |
|
|
Allosteric Inhibition of a Family of Proteolytic Enzymes |
Charles Craik, PhD |
Immunology, Pharmacology and Drug Treatment |
|
|
Identification of Cobra-specific antibodies |
Charles Craik, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Immunology |
|
|
Enabling New Translational Discoveries Using a Genomic Data-Driven Nosology |
Atul Butte, MD, PhD |
Cancer/Oncology, Immunology |
|
|
Reactivation of latent HIV using recombinant galectin-9 |
|
HIV/AIDS, Immunology |
|
|
A Novel Myeloid Subset Mediating Tolerance to Malaria |
|
Malaria, Immunology |
|
|
Exploring the role of a novel, polymorphic protein family in M. tuberculosis pathogenesis |
|
Tuberculosis, Immunology |
|
|
Treatment of SLE with ajulemic acid,a non-psychoactive cannabinoid derivative |
|
Immunology |
|
|
Trefoil Factor Proteins Modulate Host Immunity against Hookworms |
|
Zoonosis, Emerging Disease, and Drug Resistance, Immunology |
|
|
Trefoil Factors Regulate Th2 Immunity |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Immunology |
|
|
Gilead Sciences Research Scholars Program in Cystic Fibrosis. |
Oren Rosenberg, MD, PhD |
Immunology |
|
|
New ways of treating pancreatic cancer based on reversing K-Ras-mediated stemness |
|
Cancer/Oncology, Immunology |
|
|
Proteomics Analysis of Host-Pathogen Interactions in Histoplasma |
Anita Sil, MD, PhD |
Opportunistic Infection, Immunology |
|
|
Stem Cell differentiation to thymic epithelium for inducing immune tolerance to stem cells |
|
Immunology |
|
|
Zika virus infection using models of the human placenta |
Lenore Pereira, PhD |
Immunology, Newborn and Infant Health |
|
|
Regulation of Innate Immune Signaling by Lyn Kinase |
|
Immunology |
|
|
Mechanisms of Neutrophil Activation |
|
Immunology |
|
|
Immunomodulation of transplant rejection by anti-CD3 mAb |
Jeffrey Bluestone, PhD |
Immunology |
|
|
Development of Regulatory T-Cells for Treatment of Autoimmune Disease |
Jeffrey Bluestone, PhD |
Immunology, Pharmacology and Drug Treatment |
|
|
The ONE Study: A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation |
Jeffrey Bluestone, PhD |
Immunology |
|
|
Collaborative Network for Clinical Research on Immune Tolerance - Offcampus Portion |
Jeffrey Bluestone, PhD |
Diabetes, Immunology |
|
|
Collaborative Network for Clinical Research on Immune Tolerance |
Jeffrey Bluestone, PhD |
Diabetes, Immunology |
|
|
Phase II Double Blinded, Placebo-Controlled, Efficacy and Safety Evaluation of Allergen Immunotherapy Co-Administered with Omalizumab, an Anti-IgE mAb |
Jeffrey Bluestone, PhD |
Immunology |
|
|
Antigen Specificity of Regulatory T cells in Type 1 diabetes T1D |
Jeffrey Bluestone, PhD |
Diabetes, Immunology |
|
|
UCSF Comprehensive Center for Immunologic Diseases (CCID) |
Jeffrey Bluestone, PhD |
Immunology |
|
|
HLA-A Low Resolution Typing |
|
Surgery and Anesthesia, Immunology |
|
|
Development of Human mAbs to Target Cardiomyocytes and Cardiac Fibroblasts |
|
Cardiovascular Disease, Immunology |
|
|
Development of Human mABs to CXCR1 and CXCR2 |
|
Immunology |
|
|
A Pharmacogenomics Study of HIV Latency: The Role of Anti-Programmed Cell Death-1 (PD-1) Signaling |
Sulggi Lee, MD |
HIV/AIDS, Immunology |
|
|
NP25737 A Phase I Pharmacokinetic and Safety Study of Tocilizumab (TCZ) in Patients Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis |
|
Noncommunicable and/or Chronic Disease, Immunology, Pediatrics |
|
|
Childhood Arthritis and Rheumatology Research Alliance Registry (CARRA Registry): Lupus Nephritis Consensus Treatment Plan Maintenance Phase |
|
Immunology |
|
|
A 6 month Multi-center, Open-label Safety Study of VIMOVO in Adolescents |
|
Immunology, Adolescent Health |
|
|
Mechanisms of B Cell Responses in Autoimmune Disease: C12-ALE05-CSF |
|
Immunology |
|
|
A Specific Mechanism for Non-Specific Inhibition |
|
Immunology |
|
|
Oxygen Sensors and P450 Monooxygenases in Mycobacertium tuberculosis |
|
Tuberculosis, Immunology |
|
|
Creating Polyketide Antibiotic Diversity by Engineering Cytochrome P450 Enzymes / UC Discovery |
|
Immunology |
|
|
Improve the Cho Expression of a ScFv Fragment by Optimizing the DNA Sequence of the ingle chain variable fragment ScFv and/or Leader Sequence |
|
Drug and Diagnostics Development, Immunology |
|
|
Generation of therapeutic antibodies for serotype F botulism (Continuation of A120963 from NIH G Pool to Subaccount) |
|
Immunology |
|
|
HIV Vaccine Trials Network - Laboratory Personnel Support |
|
Immunology |
|
|
Host-pathogen interactions: Unveiling common mechanisms for rewiring host factors in infectious processes |
Nevan Krogan, PhD, MSc |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Immunology, Genetics |
|
|
HINT: HIV Immune Networks Team Modeling Core |
Nevan Krogan, PhD, MSc |
HIV/AIDS, Immunology |
|
|
HPMI: Host Pathogen Mapping Initiative |
Nevan Krogan, PhD, MSc |
Zoonosis, Emerging Disease, and Drug Resistance, Immunology, Genetics |
|
|
Physical and Genetic Interaction Landscape of the Tyrosine Kinome |
Nevan Krogan, PhD, MSc |
Cancer/Oncology, Diabetes, Immunology |
|
|
Global Innate Immune Responses to HIV-1 Infection |
Nevan Krogan, PhD, MSc |
HIV/AIDS, Immunology |
|
|
Naturally acquired immunity to norovirus in a newborn cohort in Peru |
Caryn Bern, MD, MPH |
Infectious Disease, Immunology, Newborn and Infant Health |
|
|
Antigen Decoding by T cells |
|
Immunology |
|
|
UCSF-GIVI Center for AIDS Research (CFAR) |
Paul Volberding, MD |
HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Drug and Diagnostics Development, Immunology, Pharmacology and Drug Treatment, Neurology and Mental Health, Trauma and PTSD, Women's Health, Pediatrics, Implementation and Behavioral Science, Training and Capacity Building, Training International Scholars and Clinicians |
|
|
Long-term Effects of IDU, HIV, HCV and the Impact of HCV Cure on Immune Activation and Liver Fibrosis in Aging Women |
Phyllis Tien, MD |
Infectious Disease, HIV/AIDS, Immunology, Women's Health |
|
|
HIV-Specific T-Cell Responses in Rectal Mucosa |
Elizabeth Sinclair, PhD |
HIV/AIDS, Immunology |
|
|
Genome-Wide Association Study to Examine Genes Associated with An Increased Risk of Febrile Seizure in Children Following Measles-Containing Vaccines |
Mark Seielstad, PhD |
Infectious Disease, Transfusion Medicine, Immunology, Pharmacology and Drug Treatment, Pediatrics, Epidemiology and Surveillance |
|
|
Novel Linkers for Antibody-Drug Conjugates |
Adam Renslo, PhD |
Immunology |
|
|
Precision Targeting of Castration Resistant Prostate Cancer with a Novel Ferrous Iron-Dependent Therapeutic Delivery and Tumor Imaging Strategy |
Adam Renslo, PhD |
Cancer/Oncology, Immunology |
|
|
CNS Immune / Inflammatory Biomarkers in HIV Controllers |
Richard Price, MD |
HIV/AIDS, Immunology |
|
|
Chemoprophylaxis and HIV-Host Interactions [II] |
|
HIV/AIDS, Immunology |
|
|
Immunological Targeting of APOBEC Proteins to Cure HIV Infection |
|
HIV/AIDS, Immunology |
|
|
Interferon-independent mechanisms of malaria restriction by helper T cells |
Mike McCune, MD, PhD |
HIV/AIDS, Malaria, Immunology |
|
|
The impact of TB co-infection on the reservoir of persistent HIV in vivo |
Mike McCune, MD, PhD |
HIV/AIDS, Tuberculosis, Immunology |
|
|
Use of r-hGh to Enhance Thymopoiesis and to Facilitate Immune Restoration in Individuals Infected with HIV-1 |
Mike McCune, MD, PhD |
HIV/AIDS, Immunology |
|
|
Regulation of Human Thymic Function in Vivo |
Mike McCune, MD, PhD |
Immunology |
|
|
Defining critical events in early HIV infection-effects of alcohol and early ART |
Mike McCune, MD, PhD |
HIV/AIDS, Immunology, Substance Abuse |
|
|
Timing of ART and homeostasis of the persistent HIV reservoir in the adult |
Mike McCune, MD, PhD |
HIV/AIDS, Immunology |
|
|
Recent Thymic Emigrants of the CD4 T-Cell Lineage |
Mike McCune, MD, PhD |
Immunology |
|
|
Project 2: Effect of Humanized Anti Pcrv Antibody on Total Bacterial Community Composition of Adult Patients with Ventilator-Associated Pneumonia |
|
Immunology |
|
|
Pets and the Infant Microbiome: Effect on Immune Maturation and Atopic Asthma |
|
Occupational and Environmental Disease, Immunology |
|
|
Initiation of allergic immunity by parasites |
Richard Locksley, MD |
Immunology |
|
|
Initiation of Allergic Immunity by Parasites |
Richard Locksley, MD |
Immunology |
|
|
Identification of the CD8+ Cell Anti-HIV Factor (CAF) |
|
HIV/AIDS, Immunology |
|
|
HIV cure with CCR5 negative human IPS hematopoietic stem cells |
|
HIV/AIDS, Drug and Diagnostics Development, Immunology |
|
|
Alcohol's impact on immunological and virological profiles in HIV patients |
Mandana Khalili, MD |
HIV/AIDS, Immunology, Substance Abuse |
|
|
747-303: A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of beticholic Acid in Subjects with Nonalcoholic Steatohepatitis |
Mandana Khalili, MD |
Immunology |
|
|
Valganciclovir to Reduce T Cell Activation in HIV Infection |
Peter Hunt, MD |
HIV/AIDS, Drug and Diagnostics Development, Immunology |
|
|
Investigating Mechanisms of HIV Persistence in the Gut |
Peter Hunt, MD |
HIV/AIDS, Immunology |
|
|
Immunologic determinants of age-related macular degeneration |
Peter Hunt, MD |
Eye Disease and Blindness, Immunology, Aging |
|
|
Impact of Cannabis on Inflammation and Viral Persistence in Treated HIV/SIV |
Peter Hunt, MD |
HIV/AIDS, Immunology |
|
|
HIV-Specific T-Cell Responses in Rectal Mucosa |
Peter Hunt, MD |
Immunology |
|
|
Effect of IL-1B inhibition on inflammation and cardiovascular risk in HIV |
|
HIV/AIDS, Immunology |
|
|
Systematic Review Series on "Antibody and Antigen Detection for the Immunodiagnosis of Tuberculosis" |
Philip Hopewell, MD |
Tuberculosis, Immunology, Systematic Reviews and Guideline Development |
|
|
ACTG A5335s Specialty Lab |
Diane Havlir, MD |
Drug and Diagnostics Development, Immunology, Genetics |
|
|
Treating HIV-Infected Elite Controllers as a Model of HIV Remission |
|
HIV/AIDS, Immunology |
|
|
Inflammatory and Clinical Consequences of Low-Level Viremia in HIV-1 Infected Patients |
|
HIV/AIDS, Immunology |
|
|
Plasmodium Falciparum Infection and Interference with Effective B Cell Memory |
Bryan Greenhouse, MD |
Malaria, Immunology, Pediatrics |
|
|
VEGF signaling in placental development and disease |
Susan Fisher, PhD |
Immunology, Labor and Delivery |
|
|
Effector and regulatory T cell responses and protection from clinical malaria |
Margaret Feeney, MD |
Malaria, Drug and Diagnostics Development, Immunology |
|
|
Microbial Pathogenesis and Host Defense |
Joanne Engel, MD, PhD |
Immunology, Residencies, Fellowships, and Postdoctoral Training |
|
|
Integrative Program in Complex Biological System (ipCBS) |
Joseph Derisi, PhD |
Drug and Diagnostics Development, Immunology, Genetics, Residencies, Fellowships, and Postdoctoral Training |
|
|
Core B: Intracellular Pathogens and Innate Immunity |
Joseph Derisi, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Immunology |
|
|
CORE B: Intracellular Pathogens and Innate Immunity |
Joseph Derisi, PhD |
Tuberculosis, Immunology |
|
|
Identifying and targeting HIV persistence in T Cell subsets during ART |
Steven Deeks, MD |
Drug and Diagnostics Development, Immunology, Genetics |
|
|
Characterizing the Role of Immune Activation in HIV Persistence |
Steven Deeks, MD |
HIV/AIDS, Immunology |
|
|
Enhancing Control of HIV by Inhibiting TRAIL |
Steven Deeks, MD |
HIV/AIDS, Drug and Diagnostics Development, Immunology |
|
|
Impact of interferon-alpha inhibition on immune function and viral persistence in HIV disease |
Steven Deeks, MD |
HIV/AIDS, Immunology |
|
|
Gender-specific Differences Affecting Reactivation of Latent HIV in Treated Patients |
Steven Deeks, MD |
HIV/AIDS, Immunology, Women's Health |
|
|
HIV Controllers: A Potential Model for HIV Eradication |
Steven Deeks, MD |
HIV/AIDS, Immunology |
|
|
HIV Entry Inhibitors: A New Therapeutic Option |
Steven Deeks, MD |
HIV/AIDS, Immunology |
|
|
Effects of CCR5 - delta-32 Heterozygosity on the HIV-1 Reservoir |
Steven Deeks, MD |
HIV/AIDS, Immunology, Genetics |
|
|
Elite Controllers |
Steven Deeks, MD |
HIV/AIDS, Immunology, Genetics |
|
|
Raltegravir Intensification in Antiretroviral-Treated Patients Exhibiting a Suboptimal CD4+T Cell Response |
Steven Deeks, MD |
HIV/AIDS, Immunology |
|
|
Innate Effector Function and HIV-1 Control |
Steven Deeks, MD |
HIV/AIDS, Immunology |
|
|
Programming Long Term Durable HIV-1 Specific T cell Responses |
Steven Deeks, MD |
HIV/AIDS, Immunology |
|
|
UCSF/Ragon Collaboration on HIV "Elite" Controllers |
Steven Deeks, MD |
HIV/AIDS, Drug and Diagnostics Development, Immunology, Genetics |
|
|
T Regulatory Cells and T Cell Activation in HIV Disease |
Steven Deeks, MD |
HIV/AIDS, Immunology |
|
|
Mother-child genetic contributions to autoimmunity |
|
Immunology |
|
|
Medical and Graduate Student Preceptorship - Mok |
|
Immunology, Residencies, Fellowships, and Postdoctoral Training |
|
|
A pilot study of DNA methylation and response to treatment in RA |
|
Immunology |
|
|
Immunogenetic Studies of Autoimmune Disease |
|
Immunology |
|
|
Health Professional Research Preceptorship |
|
Immunology, Residencies, Fellowships, and Postdoctoral Training |
|
|
DNA methylation profiling in Rheumatoid Arthritis |
|
Immunology |
|
|
Health Professional Research Preceptorship |
|
Immunology, Residencies, Fellowships, and Postdoctoral Training |
|
|
Health Professional Research Preceptorship |
|
Immunology |
|
|
Host-Directed Strategies to Create Synergistic Antibacterial Therapies |
|
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development, Immunology |
|
|
Discovery of novel, ubiquitin-regulated mechanisms of TB control by macrophages |
|
Tuberculosis, Immunology |
|
|
University of California Global Health Institute Program for Fellows and Scholars |
Craig Cohen, MD, MPH |
Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Effectiveness, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, Policy and Standards of Care, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training |
|
|
Genetic Diversity as a Determinant of Viral Adaptation and Pathogenesis |
Raul Andino-Pavlovsky, PhD |
Infectious Disease, Immunology |
|
|
BSL3 upgrading for Live-attenuated poliovirus testing |
Raul Andino-Pavlovsky, PhD |
Infectious Disease, Immunology |
|
|
Testing novel adjuvants to enhance mucosal immunity elicited by inactivated poliovirus vaccine (IPV) |
Raul Andino-Pavlovsky, PhD |
Drug and Diagnostics Development, Immunology |
|
|
Selective AAK1 and GAK inhibitors for combating Dengue and other emerging viral infections |
Raul Andino-Pavlovsky, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Immunology |
|
|